HOME >> BIOLOGY >> NEWS
'Looking' at Eyeless from two directions

HOUSTON -- (March 9, 2006) When Dr. Rui Chen, assistant professor in the Baylor College of Medicine Human Genome Sequencing Center, sought to understand further the protein called Eyeless, he faced a dilemma.

Eyeless is a transcription factor, which means one of its major activities is to turn off or turn on other genes that have an effect on eye development later in the process. It is so powerful that when it is inserted into almost any tissues of the fruit fly, eyes grow often in unexpected places.

Because Eyeless is a critical factor in the development of eyes in fruit flies or Drosophila, (a common model organism for studying how different organs grow), understanding the genes it affects could offer key clues into how the organs for sight actually develop in fruit flies and ultimately people.

One method for locating these genes is called a microarray, a tiny DNA chip used to identify specific sequences of genetic material. A microarray can provide hundreds of candidate genes too many to be useful. Another method is to use bioinformatics and computers to predict where transcription factors bind, but this can give thousands of candidate genes. Again, that's too much information to be valuable.

Chen, however, took a different tack. He used both methods. Then he dealt with only the genes and binding sequences that were found by both. Of the 300 genes found by microarray and 10,000 or more by the binding site technique, only 21 were found by both.

Because 11 of these were known to play a key role in eye development, he knew he was on the right track. A report of his work appears online today in the journal Genome Research.

"The reason I like this project is that it provides the possibility of doing this in almost any species," said Chen. "It's a combination of genomic and biologic techniques."

"Finding specific targets of a transcription factor is the Holy Grail for many biologists," said Dr. Graeme Mardon,
'"/>

Contact: Ross Tomlin
htomlin@bcm.edu
713-798-4712
Baylor College of Medicine
8-Mar-2006


Page: 1 2

Related biology news :

1. Studies suggest promising new directions for gallstone treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Looking Eyeless from two directions

(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
(Date:6/18/2013)... of breast and ovarian cancers are familial in origin, ... to inherited mutations from the parents in genes such ... PARP inhibitors, which are currently in clinical trials, have ... for personalised cancer treatment, an alternative to standard chemotherapy. ... these patients generate resistance to the drug and, therefore, ...
(Date:6/17/2013)... in the U.S. exposed to high levels of air pollution ... a child with autism as women who lived in areas ... School of Public Health (HSPH). It is the first large ... across the U.S. , "Our findings raise concerns since, depending ... our study lived in areas where risk of autism was ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
(Date:6/18/2013)... -- RegeneCure announced today the start ... Bone Regeneration (GBR) Dental Membrane as a bone stimulating aid ... encountered when patients have a tooth replaced with a dental ... the implant. Consequently there is often a need to support ... regenerates. The bone substitute material, in turn, needs to be ...
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
Cached News: